<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38869283</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>VP1 is the primary determinant of neuropathogenesis in a mouse model of enterovirus D68 acute flaccid myelitis.</ArticleTitle><Pagination><StartPage>e0039724</StartPage><MedlinePgn>e0039724</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00397-24</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00397-24</ELocationID><Abstract><AbstractText Label="UNLABELLED">Enterovirus D68 (EV-D68) is an emerging pathogen that can cause severe respiratory and neurologic disease [acute flaccid myelitis (AFM)]. Intramuscular (IM) injection of neonatal Swiss Webster (SW) mice with US/IL/14-18952 (IL52), a clinical isolate from the 2014 EV-D68 epidemic, results in many of the pathogenic features of human AFM, including viral infection of the spinal cord, death of motor neurons, and resultant progressive paralysis. In distinction, CA/14-4231 (CA4231), another clinical isolate from the 2014 EV-D68 outbreak, does not cause paralysis in mice, does not grow in the spinal cord, and does not cause motor neuron loss following IM injection. A panel of chimeric viruses containing sequences from IL52 and CA4231 was used to demonstrate that VP1 is the main determinant of EV-D68 neurovirulence following IM injection of neonatal SW mice. VP1 contains four amino acid differences between IL52 and CA4231. Mutations resulting in substituting these four amino acids (CA4231 residues into the IL52 polyprotein) completely abolished neurovirulence. Conversely, mutations resulting in substituting VP1 IL52 amino acid residues into the CA4231 polyprotein created a virus that induced paralysis to the same degree as IL52. Neurovirulence following infection of neonatal SW mice with parental and chimeric viruses was associated with viral growth in the spinal cord.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Emerging viruses allow us to investigate mutations leading to increased disease severity. Enterovirus D68 (EV-D68), once the cause of rare cases of respiratory illness, recently acquired the ability to cause severe respiratory and neurologic disease. Chimeric viruses were used to demonstrate that viral structural protein VP1 determines growth in the spinal cord, motor neuron loss, and paralysis following intramuscular (IM) injection of neonatal Swiss Webster (SW) mice with EV-D68. These results have relevance for predicting the clinical outcome of future EV-D68 epidemics as well as targeting retrograde transport as a potential strategy for treating virus-induced neurologic disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leser</LastName><ForeName>J Smith</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frost</LastName><ForeName>Joshua L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-6517-4966</Identifier><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Courtney J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rudy</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-3936-6849</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Penny</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5540-2910</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyler</LastName><ForeName>Kenneth L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0003-3294-5888</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Service, Rocky Mountain VA Medical Center, Aurora, Colorado, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AI171275</GrantID><Agency>HHS | National Institutes of Health (NIH)</Agency><Country /></Grant><Grant><GrantID>R01 AI171275</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS101208</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS101208</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS101208</GrantID><Agency>HHS | National Institutes of Health (NIH)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="Y">Myelitis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="Y">Neuromuscular Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="Y">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="Y">Central Nervous System Viral Diseases</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AFM</Keyword><Keyword MajorTopicYN="N">EV-D68</Keyword><Keyword MajorTopicYN="N">VP1</Keyword><Keyword MajorTopicYN="N">neurovirulence</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>13</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>13</Day><Hour>9</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38869283</ArticleId><ArticleId IdType="pmc">PMC11264684</ArticleId><ArticleId IdType="doi">10.1128/jvi.00397-24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schieble JH, Fox VL, Lennette EH. 1967. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol 85:297–310. doi:10.1093/oxfordjournals.aje.a120693</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120693</ArticleId><ArticleId IdType="pubmed">4960233</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M, Parker EPK, Grassly NC. 2015. The epidemiology of non-polio enteroviruses: recent advances and outstanding questions. Curr Opin Infect Dis 28:479–487. doi:10.1097/QCO.0000000000000187</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000187</ArticleId><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomqvist S, Savolainen C, Råman L, Roivainen M, Hovi T. 2002. Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol 40:4218–4223. doi:10.1128/JCM.40.11.4218-4223.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.40.11.4218-4223.2002</ArticleId><ArticleId IdType="pmc">PMC139630</ArticleId><ArticleId IdType="pubmed">12409401</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Schnurr D, Flemister MR, Lovchik JC, Peters H, Sessions W, Kirk C, Chatterjee N, Fuller S, Hanauer JM, Pallansch MA. 2004. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol 85:2577–2584. doi:10.1099/vir.0.79925-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79925-0</ArticleId><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetsuriani N, Lamonte-Fowlkes A, Oberst S, Pallansch MA, Centers for Disease Control and Prevention . 2006. Enterovirus surveillance—United States, 1970–2005. MMWR Surveill Summ 55:1–20.</Citation><ArticleIdList><ArticleId IdType="pubmed">16971890</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer A, van der Sanden S, Snijders BEP, Jaramillo-Gutierrez G, Bont L, van der Ent CK, Overduin P, Jenny SL, Jusic E, van der Avoort H, Smith GJD, Donker GA, Koopmans MPG. 2012. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology 423:49–57. doi:10.1016/j.virol.2011.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.11.021</ArticleId><ArticleId IdType="pubmed">22177700</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura T, Fuji N, Suzuki A, Tamaki R, Saito M, Aniceto R, Galang H, Sombrero L, Lupisan S, Oshitani H. 2011. Enterovirus 68 among children with severe acute respiratory infection, the Philippines. Emerg Infect Dis 17:1430–1435. doi:10.3201/eid1708.101328</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1708.101328</ArticleId><ArticleId IdType="pmc">PMC3381551</ArticleId><ArticleId IdType="pubmed">21801620</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YP, Lin TL, Lin TH, Wu HS. 2017. Molecular and epidemiological study of enterovirus D68 in Taiwan. J Microbiol Immunol Infect 50:411–417. doi:10.1016/j.jmii.2015.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2015.07.015</ArticleId><ArticleId IdType="pubmed">26458357</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd AK, Hall RJ, Wang J, Peacey M, McTavish S, Rand CJ, Stanton JA, Taylor S, Huang QS. 2013. Detection and whole genome sequence analysis of an enterovirus 68 cluster. Virol J 10:103. doi:10.1186/1743-422X-10-103</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-103</ArticleId><ArticleId IdType="pmc">PMC3621541</ArticleId><ArticleId IdType="pubmed">23548106</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC . 2014. Enterovirus D68. Available from: https://www.cdc.gov/non-polio-enterovirus/about/ev-d68.html#2014</Citation></Reference><Reference><Citation>Messacar K, Schreiner TL, Maloney JA, Wallace A, Ludke J, Oberste MS, Nix WA, Robinson CC, Glodé MP, Abzug MJ, Dominguez SR. 2015. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet 385:1662–1671. doi:10.1016/S0140-6736(14)62457-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)62457-0</ArticleId><ArticleId IdType="pubmed">25638662</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson GR, Bonkowsky JL, Doll E, Green M, Hedlund GL, Moore KR, Bale JF. 2016. Recognition and management of acute flaccid myelitis in children. Pediatr Neurol 55:17–21. doi:10.1016/j.pediatrneurol.2015.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2015.10.007</ArticleId><ArticleId IdType="pubmed">26621554</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastula DM, Aliabadi N, Haynes AK, Messacar K, Schreiner T, Maloney J, Dominguez SR, Davizon ES, Leshem E, Fischer M, Nix WA, Oberste MS, Seward J, Feikin D, Miller L, Centers for Disease Control and Prevention (CDC) . 2014. Acute neurologic illness of unknown etiology in children—Colorado, August-September 2014. MMWR Morb Mortal Wkly Rep 63:901–902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4584613</ArticleId><ArticleId IdType="pubmed">25299607</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Haren K, Ayscue P, Waubant E, Clayton A, Sheriff H, Yagi S, Glenn-Finer R, Padilla T, Strober JB, Aldrovandi G, Wadford DA, Chiu CY, Xia D, Harriman K, Watt JP, Glaser CA. 2015. Acute flaccid myelitis of unknown etiology in California, 2012–2015. JAMA 314:2663–2671. doi:10.1001/jama.2015.17275</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.17275</ArticleId><ArticleId IdType="pubmed">26720027</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley CM, Watson JT, Nix WA, Curns AT, Rogers SL, Brown BA, Conover C, Dominguez SR, Feikin DR, Gray S, et al. . 2015. Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation. Lancet Respir Med 3:879–887. doi:10.1016/S2213-2600(15)00335-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(15)00335-5</ArticleId><ArticleId IdType="pmc">PMC5693332</ArticleId><ArticleId IdType="pubmed">26482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Haren K, Ayscue P, Waubant E, Clayton A, Sheriff H, Yagi S, Glenn-Finer R, Padilla T, Strober JB, Aldrovandi G, Wadford DA, Chiu CY, Xia D, Harriman K, Watt JP, Glaser CA. 2015. Acute flaccid myelitis of unknown etiology in California, 2012-2015. JAMA 314:2663–2671. doi:10.1001/jama.2015.17275</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.17275</ArticleId><ArticleId IdType="pubmed">26720027</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney JA, Mirsky DM, Messacar K, Dominguez SR, Schreiner T, Stence NV. 2015. MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak. AJNR Am J Neuroradiol 36:245–250. doi:10.3174/ajnr.A4188</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4188</ArticleId><ArticleId IdType="pmc">PMC7965662</ArticleId><ArticleId IdType="pubmed">25414005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu YL, Chang LY. 2020. Current status of enterovirus D68 worldwide and in Taiwan. Pediatr Neonatol 61:9–15. doi:10.1016/j.pedneo.2019.09.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pedneo.2019.09.007</ArticleId><ArticleId IdType="pubmed">31706947</ArticleId></ArticleIdList></Reference><Reference><Citation>Skowronski DM, Chambers C, Sabaiduc S, Murti M, Gustafson R, Pollock S, Hoyano D, Rempel S, Allison S, De Serres G, Dickinson JA, Tellier R, Fonseca K, Drews SJ, Martineau C, Reyes-Domingo F, Wong T, Tang P, Krajden M. 2015. Systematic community- and hospital-based surveillance for enterovirus-D68 in three Canadian provinces, August to December 2014. Euro Surveill 20:30047. doi:10.2807/1560-7917.ES.2015.20.43.30047</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2015.20.43.30047</ArticleId><ArticleId IdType="pubmed">26804195</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuffenecker I, Mirand A, Josset L, Henquell C, Hecquet D, Pilorgé L, Petitjean-Lecherbonnier J, Manoha C, Legoff J, Deback C, Pillet S, Lepiller Q, Mansuy JM, Marque-Juillet S, Antona D, Peigue-Lafeuille H, Lina B. 2016. Epidemiological and clinical characteristics of patients infected with enterovirus D68, France, July to December 2014. Euro Surveill 21:30226. doi:10.2807/1560-7917.ES.2016.21.19.30226</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.19.30226</ArticleId><ArticleId IdType="pubmed">27195770</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragstad K, Jakobsen K, Rojahn AE, Skram MK, Vainio K, Holberg-Petersen M, Hungnes O, Dudman SG, Kran A-M. 2015. High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014. Influenza Other Respir Viruses 9:59–63. doi:10.1111/irv.12300</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12300</ArticleId><ArticleId IdType="pmc">PMC4353317</ArticleId><ArticleId IdType="pubmed">25534826</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggieri V, Paz MI, Peretti MG, Rugilo C, Bologna R, Freire C, Vergel S, Savransky A. 2017. Enterovirus D68 infection in a cluster of children with acute flaccid myelitis, Buenos Aires, Argentina, 2016. Eur J Pediatr Neurol 21:884–890. doi:10.1016/j.ejpn.2017.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2017.07.008</ArticleId><ArticleId IdType="pubmed">28747261</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoester M, Schölvinck EH, Poelman R, Smit S, Vermont CL, Niesters HGM, Van Leer-Buter CC. 2017. Upsurge of enterovirus D68, the Netherlands, 2016. Emerg Infect Dis 23:140–143. doi:10.3201/eid2301.161313</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2301.161313</ArticleId><ArticleId IdType="pmc">PMC5176244</ArticleId><ArticleId IdType="pubmed">27660916</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrion Martin AI, Pebody RG, Danis K, Ellis J, Niazi S, DE Lusignan S, Brown KE, Zambon M, Allen DJ. 2017. The emergence of enterovirus D68 in England in autumn 2014 and the necessity for reinforcing enterovirus respiratory screening. Epidemiol Infect 145:1855–1864. doi:10.1017/S0950268817000590</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268817000590</ArticleId><ArticleId IdType="pmc">PMC9203298</ArticleId><ArticleId IdType="pubmed">28367789</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiche J, Böttcher S, Diedrich S, Buchholz U, Buda S, Haas W, Schweiger B, Wolff T. 2015. Low-level circulation of enterovirus D68-associated acute respiratory infections. Emerg Infect Dis 21:837–841. doi:10.3201/eid2105.141900</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2105.141900</ArticleId><ArticleId IdType="pmc">PMC4412236</ArticleId><ArticleId IdType="pubmed">25898320</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Pretty K, Reno S, Dominguez SR. 2019. Continued biennial circulation of enterovirus D68 in Colorado. J Clin Virol 113:24–26. doi:10.1016/j.jcv.2019.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2019.01.008</ArticleId><ArticleId IdType="pubmed">30825833</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Zhuge J, Huang W, Nolan SM, Gilrane VL, Yin C, Dimitrova N, Fallon JT. 2017. Enterovirus D68 subclade B3 strain circulating and causing an outbreak in the United States in 2016. Sci Rep 7:1242. doi:10.1038/s41598-017-01349-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01349-4</ArticleId><ArticleId IdType="pmc">PMC5430842</ArticleId><ArticleId IdType="pubmed">28455514</ArticleId></ArticleIdList></Reference><Reference><Citation>González-Sanz R, Taravillo I, Reina J, Navascués A, Moreno-Docón A, Aranzamendi M, Romero MP, Del Cuerpo M, Pérez-González C, Pérez-Castro S, Otero A, Cabrerizo M. 2019. Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018. Emerg Microbes Infect 8:1438–1444. doi:10.1080/22221751.2019.1668243</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2019.1668243</ArticleId><ArticleId IdType="pmc">PMC6781473</ArticleId><ArticleId IdType="pubmed">31571527</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JT, Shih WL, Yen TY, Cheng AL, Lu CY, Chang LY, Huang LM. 2020. Enterovirus D68 seroepidemiology in Taiwan, a cross sectional study from 2017. PLoS ONE 15:e0230180. doi:10.1371/journal.pone.0230180</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230180</ArticleId><ArticleId IdType="pmc">PMC7064212</ArticleId><ArticleId IdType="pubmed">32155216</ArticleId></ArticleIdList></Reference><Reference><Citation>Force T. 2019. An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018–21 January 2019: early findings. Euro Surveill 24:1900093. doi:10.2807/1560-7917.ES.2019.24.6.1900093</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.6.1900093</ArticleId><ArticleId IdType="pmc">PMC6373064</ArticleId><ArticleId IdType="pubmed">30755296</ArticleId></ArticleIdList></Reference><Reference><Citation>Carballo CM, Erro MG, Sordelli N, Vazquez G, Mistchenko AS, Cejas C, Rodriguez M, Cisterna DM, Freire MC, Contrini MM, Lopez EL. 2019. Acute flaccid myelitis associated with enterovirus D68 in children, Argentina, 2016. Emerg Infect Dis 25:573–576. doi:10.3201/eid2503.170897</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2503.170897</ArticleId><ArticleId IdType="pmc">PMC6390768</ArticleId><ArticleId IdType="pubmed">30602120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bal A, Sabatier M, Wirth T, Coste-Burel M, Lazrek M, Stefic K, Brengel-Pesce K, Morfin F, Lina B, Schuffenecker I, Josset L. 2019. Emergence of enterovirus D68 clade D1, France, August to November 2018. Euro Surveill 24:1800699. doi:10.2807/1560-7917.ES.2019.24.3.1800699</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.3.1800699</ArticleId><ArticleId IdType="pmc">PMC6344839</ArticleId><ArticleId IdType="pubmed">30670143</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt MR, Wright PF, Hickey WF, De Buysscher T, Boyd KL, Crowe JE. 2022. Enterovirus D68 in the anterior horn cells of a child with acute flaccid myelitis. N Engl J Med 386:2059–2060. doi:10.1056/NEJMc2118155</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2118155</ArticleId><ArticleId IdType="pmc">PMC9321432</ArticleId><ArticleId IdType="pubmed">35613028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Yu G, Leser JS, Yagi S, Clarke P, Chiu CY, Tyler KL. 2017. A mouse model of paralytic myelitis caused by enterovirus D68. PLoS Pathog 13:e1006199. doi:10.1371/journal.ppat.1006199</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006199</ArticleId><ArticleId IdType="pmc">PMC5322875</ArticleId><ArticleId IdType="pubmed">28231269</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Bian L, Gao F, Du R, Hu Y, Fu Y, Su Y, Wu X, Mao Q, Liang Z. 2019. A neonatal mouse model of enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis. Antiviral Res 161:108–115. doi:10.1016/j.antiviral.2018.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.11.013</ArticleId><ArticleId IdType="pubmed">30503887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Zhang X, Dai W, Liu Q, Xiong P, Wang S, Geng L, Gong S, Huang Z. 2018. A mouse model of enterovirus D68 infection for assessment of the efficacy of inactivated vaccine. Viruses 10:58. doi:10.3390/v10020058</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v10020058</ArticleId><ArticleId IdType="pmc">PMC5850365</ArticleId><ArticleId IdType="pubmed">29385753</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans WJ, Hurst BL, Peterson CJ, Van Wettere AJ, Day CW, Smee DF, Tarbet EB. 2019. Development of a respiratory disease model for enterovirus D68 in 4-week-old mice for evaluation of antiviral therapies. Antiviral Res 162:61–70. doi:10.1016/j.antiviral.2018.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.11.012</ArticleId><ArticleId IdType="pmc">PMC6997929</ArticleId><ArticleId IdType="pubmed">30521834</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh MT, Capponi S, Catching A, Bianco S, Andino R. 2020. Mapping attenuation determinants in enterovirus-D68. Viruses 12:867. doi:10.3390/v12080867</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12080867</ArticleId><ArticleId IdType="pmc">PMC7472100</ArticleId><ArticleId IdType="pubmed">32784424</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Clarke P, Tyler KL. 2017. Evaluating treatment efficacy in a mouse model of enterovirus D68-associated paralytic myelitis. J Infect Dis 216:1245–1253. doi:10.1093/infdis/jix468</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix468</ArticleId><ArticleId IdType="pmc">PMC5853295</ArticleId><ArticleId IdType="pubmed">28968718</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost J, Rudy MJ, Leser JS, Tan H, Hu Y, Wang J, Clarke P, Tyler KL. 2023. Telaprevir treatment reduces paralysis in a mouse model of enterovirus D68 acute flaccid myelitis. J Virol 97:e0015623. doi:10.1128/jvi.00156-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00156-23</ArticleId><ArticleId IdType="pmc">PMC10231134</ArticleId><ArticleId IdType="pubmed">37154751</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudy MJ, Frost J, Clarke P, Tyler KL. 2022. Neutralizing antibody given after paralysis onset reduces the severity of paralysis compared to nonspecific antibody-treated controls in a mouse model of EV-D68-associated acute flaccid myelitis. Antimicrob Agents Chemother 66:e0022722. doi:10.1128/aac.00227-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aac.00227-22</ArticleId><ArticleId IdType="pmc">PMC9380545</ArticleId><ArticleId IdType="pubmed">35894595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Clarke P, Tyler KL. 2019. Contemporary circulating enterovirus D68 strains infect and undergo retrograde axonal transport in spinal motor neurons independent of sialic acid. J Virol 93:e00578-19. doi:10.1128/JVI.00578-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00578-19</ArticleId><ArticleId IdType="pmc">PMC6675884</ArticleId><ArticleId IdType="pubmed">31167912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd S, Lopez AS, Konopka-Anstadt JL, Nix WA, Routh JA, Oberste MS. 2020. Enterovirus D68–associated acute flaccid myelitis, United States, 2020. Emerg Infect Dis 26:e201630. doi:10.3201/eid2610.201630</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2610.201630</ArticleId><ArticleId IdType="pmc">PMC7510737</ArticleId><ArticleId IdType="pubmed">32833616</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathanson N, Langmuir AD. 1963. The cutter incident. Poliomyelitis following formaldehyde- inactivated poliovirus vaccination in the United States during the spring of 1955. I. Background. Am J Hyg 78:16–28. doi:10.1093/oxfordjournals.aje.a120327</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a120327</ArticleId><ArticleId IdType="pubmed">14043543</ArticleId></ArticleIdList></Reference><Reference><Citation>Howe HA, Bodian D. 1942. Neural mechanisms in poliomyelitis. In New York: commonwealth fund</Citation></Reference><Reference><Citation>Ren R, Racaniello VR. 1992. Human poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice. J Virol 66:296–304. doi:10.1128/JVI.66.1.296-304.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.66.1.296-304.1992</ArticleId><ArticleId IdType="pmc">PMC238287</ArticleId><ArticleId IdType="pubmed">1370085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromeier M, Wimmer E. 1998. Mechanism of injury-provoked poliomyelitis. J Virol 72:5056–5060. doi:10.1128/JVI.72.6.5056-5060.1998</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.6.5056-5060.1998</ArticleId><ArticleId IdType="pmc">PMC110068</ArticleId><ArticleId IdType="pubmed">9573275</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A, Bhatnagar J, Zaki SR. 2015. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol 235:217–228. doi:10.1002/path.4438</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4438</ArticleId><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuse Y, Chaimongkol N, Okamoto M, Oshitani H. 2019. Evolutionary and functional diversity of the 5′ untranslated region of enterovirus D68: increased activity of the internal ribosome entry site of viral strains during the 2010s. Viruses 11:626. doi:10.3390/v11070626</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070626</ArticleId><ArticleId IdType="pmc">PMC6669567</ArticleId><ArticleId IdType="pubmed">31288421</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike S, Nagata N. 2016. A transgenic mouse model of poliomyelitis. Methods Mol Biol 1387:129–144. doi:10.1007/978-1-4939-3292-4_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-3292-4_7</ArticleId><ArticleId IdType="pubmed">26983733</ArticleId></ArticleIdList></Reference><Reference><Citation>Aknouch I, García-Rodríguez I, Giugliano FP, Calitz C, Koen G, van Eijk H, Johannessson N, Rebers S, Brouwer L, Muncan V, Stittelaar KJ, Pajkrt D, Wolthers KC, Sridhar A. 2023. Amino acid variation at VP1-145 of enterovirus A71 determines the viral infectivity and receptor usage in a primary human intestinal model. Front Microbiol 14:1045587. doi:10.3389/fmicb.2023.1045587</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1045587</ArticleId><ArticleId IdType="pmc">PMC10149690</ArticleId><ArticleId IdType="pubmed">37138595</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht H-J, Johnson JE, Kamer G, Luo M, Mosser AG, Rueckert RR, Sherry B, Vriend G. 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317:145–153. doi:10.1038/317145a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/317145a0</ArticleId><ArticleId IdType="pubmed">2993920</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Sheng J, Baggen J, Meng G, Xiao C, Thibaut HJ, van Kuppeveld FJM, Rossmann MG. 2015. Sialic acid-dependent cell entry of human enterovirus D68. Nat Commun 6:8865. doi:10.1038/ncomms9865</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9865</ArticleId><ArticleId IdType="pmc">PMC4660200</ArticleId><ArticleId IdType="pubmed">26563423</ArticleId></ArticleIdList></Reference><Reference><Citation>Ida-Hosonuma M, Iwasaki T, Yoshikawa T, Nagata N, Sato Y, Sata T, Yoneyama M, Fujita T, Taya C, Yonekawa H, Koike S. 2005. The alpha/beta interferon response controls tissue tropism and pathogenicity of poliovirus. J Virol 79:4460–4469. doi:10.1128/JVI.79.7.4460-4469.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.7.4460-4469.2005</ArticleId><ArticleId IdType="pmc">PMC1061561</ArticleId><ArticleId IdType="pubmed">15767446</ArticleId></ArticleIdList></Reference><Reference><Citation>Elrick MJ, Pekosz A, Duggal P. 2021. Enterovirus D68 molecular and cellular biology and pathogenesis. J Biol Chem 296:100317. doi:10.1016/j.jbc.2021.100317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100317</ArticleId><ArticleId IdType="pmc">PMC7949111</ArticleId><ArticleId IdType="pubmed">33484714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauna ZE, Kimchi-Sarfaty C. 2011. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12:683–691. doi:10.1038/nrg3051</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3051</ArticleId><ArticleId IdType="pubmed">21878961</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma Y, Miladi M, Dukare S, Boulay K, Caudron-Herger M, Groß M, Backofen R, Diederichs S. 2019. A pan-cancer analysis of synonymous mutations. Nat Commun 10:2569. doi:10.1038/s41467-019-10489-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10489-2</ArticleId><ArticleId IdType="pmc">PMC6562042</ArticleId><ArticleId IdType="pubmed">31189880</ArticleId></ArticleIdList></Reference><Reference><Citation>Pechmann S, Frydman J. 2013. Evolutionary conservation of codon optimality reveals hidden signatures of co-translational folding. Nat Struct Mol Biol 20:237–243. doi:10.1038/nsmb.2466</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2466</ArticleId><ArticleId IdType="pmc">PMC3565066</ArticleId><ArticleId IdType="pubmed">23262490</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa RS, Copeland BR, Mustoe AM, Goldstein DB. 2020. Natural selection shapes codon usage in the human genome. Am J Hum Genet 107:83–95. doi:10.1016/j.ajhg.2020.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2020.05.011</ArticleId><ArticleId IdType="pmc">PMC7332603</ArticleId><ArticleId IdType="pubmed">32516569</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>